The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
Abstract
Insulin resistance and dyslipidemia have been described in women with polycystic ovary syndrome (PCOS), a disorder characterized by hyperandrogenism and oligomenorrhea. Although oral contraceptives (OC) are often instituted to regulate menses and suppress HA in women with PCOS, their use has been postulated to cause a deterioration in insulin sensitivity and to adversely affect circulating lipids. To investigate these effects, 9 women with PCOS and 10 age- and weight-matched control women were studied before and during the third month of therapy with a low-dose norethindrone-containing triphasic combination OC using the hyperglycemic clamp technique. At baseline, the PCOS group had higher androgen, triglyceride, and glycosylated hemoglobin concentrations, with a greater insulin response to oral glucose and a lower insulin sensitivity index (ISI) than controls. During OC therapy, a reduction in ISI was observed in both groups, whereas an increase in triglycerides was observed only in controls, removing any observed difference between the two groups in ISI or lipids. In women with PCOS, an increase in insulin concentrations during hyperglycemia accounted for the decline in ISI (P = 0.026), whereas in control women the decrease in ISI was attributable to a decrease in glucose disposal (P = 0.004). In conclusion, PCOS is characterized by insulin resistance in the untreated state. Short-term therapy with a triphasic OC results in a further decline in ISI in women with PCOS, without inducing additional adverse effects on lipids. A more pronounced decline in ISI together with an elevation in triglyceride levels occurs in normal women with OCs. The mechanisms leading to this decrease in ISI are different for each group.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“COCP does not have any major effects on carbohydrate metabolism in healthy women, whereas the effect on lipid metabolism depends on the level of estrogen and type of progestin, with potential negative effects (78, 79, 80, 81).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [78]
In the citing paper
“COCP does not have any major effects on carbohydrate metabolism in healthy women, whereas the effect on lipid metabolism depends on the level of estrogen and type of progestin, with potential negative effects (78, 79, 80, 81).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [78]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative Determination of Serum Triglycerides by the Use of Enzymes
Bucolo, G., & David, H. (1973) · Clinical Chemistry · doi:10.1093/clinchem/19.5.476 · Cited by 3,184
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Validation of tetrapolar bioelectrical impedance method to assess human body composition
Lukaski, H. C., Bolonchuk, W. W., Hall, C. B., & Siders, W. A. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.4.1327 · Cited by 1,370
Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study
Segal, K., Van Loan, M., Fitzgerald, P., Hodgdon, A., & Van Itallie, T. (1988) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/47.1.7 · Cited by 881
NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815
Barbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
Dunaif, A. E., GRAF, M., Mandeli, J., Laumas, V., & Dobrjansky, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 577
Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–139 of 139
Perspective in the treatment of insulin resistance
Scheen, A. J. (1997) · Human Reproduction · doi:10.1093/humrep/12.suppl_1.63 · Cited by 9
Treatment for polycystic ovary syndrome: a critical appraisal of treatment options
Nader, S. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.3.349 · Cited by 9
Glucose tolerance, insulin secretion and insulin sensitivity in polycystic ovary syndrome.
Pasquali, R., Pelusi, C., Ragazzini, C., Hasanaj, R., & Gambineri, A. (2002) · PubMed · Cited by 9
Role of Lipid Management in Women’s Health Preventive Care
Hosseinzadeh, P., & Wild, R. A. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2020.11.003 · Cited by 8
Copperman, A. B., Mukherjee, T., & KASE, N. G. (2003) · Elsevier eBooks · doi:10.1016/b978-012053642-9/50029-6 · Cited by 7
Diamanti‐Kandarakis, E., Baillargeon, J., & Jurno, M. J. (2003) · Cited by 6
Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome
Koivunen, R. M. (2001) · Cited by 5
Current procedures for managing polycystic ovary syndrome
Massicotte, M.-H., Langlois, F., & Baillargeon, J. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.09.74 · Cited by 5
Should patients with polycystic ovarian syndrome be treated with metformin
Nestler, J. E. (2002) · Cited by 5
Advances in the treatment of polycystic ovary syndrome
Moghetti, P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1631 · Cited by 4
Diamanti‐Kandarakis, E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_32 · Cited by 4
Javed, A., Lteif, A. N., Kumar, S., Simmons, P. S., & Chang, A. Y. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.01.001 · Cited by 5
Therapy for polycystic ovarian syndrome
WEI, A., & Pritts, E. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.06.004 · Cited by 3
Clinical Implications of Insulin-Like Growth Factors and Their Binding Proteins in Reproduction.
Yoshimura, Y. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.493 · Cited by 3
Coussa, A., Hasan, H. A., & Barber, T. M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14270 · Cited by 2
Chronic Treatment of Polycystic Ovary Syndrome
Nader, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_9 · Cited by 2
Metformin effects on Polycystic Ovarian Syndrome
Barrouq, D. M. S., & Unni, B. R. (2023) · East African Scholars Journal of Medical Sciences · doi:10.36349/easms.2023.v06i03.002 · Cited by 1
Johnston-MacAnanny, E. B., Park, J. K., & Berga, S. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6837-0_8 · Cited by 2
Self-citationHyperandrogénie chez l'adolescente
Richard, C., Jonard, S., & Dewailly, D. (2006) · EMC - Gynécologie · doi:10.1016/s0246-1064(06)43120-0 · Cited by 2
Insulin resistance in polycystic ovary syndrome
Morin-Papunen, L. C. (2000) · Cited by 2
Treatment of polycystic ovary syndrome: recent trial results
Ganie, M. A., Chakraborty, S., & Rehman, H. (2015) · Clinical Investigation · doi:10.4155/cli.14.133 · Cited by 1
Zaburzenia gospodarki węglowodanowej u kobiet z zespołem wielotorbielowatych jajników (PCOS)
Kuligowska-Jakubowska, M. (2012) · Cited by 1
The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
Sharma, S. T., & Nestler, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_10 · Cited by 1
Oxidative Stress Impact on the Fertility of Women with Polycystic Ovary Syndrome
Aponte, A., & Agarwal, A. K. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-041-0_10 · Cited by 1
Therapeutic Aspects of Polycystic Ovary Syndrome in Adolescence
Koliopoulos, C., & Creatsas, G. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_27 · Cited by 1
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Women, Pregnancy, and Gestational Diabetes
Dunning, T. (2009) · doi:10.1002/9781444320893.ch14
Sokol, R. Z., & Shoupe, D. (2010) · doi:10.1002/9781444323030.ch92
Síndrome de ovario poliquístico en la adolescente
Pfeifer, S. M., & Kives, S. L. (2009) · Clínicas obstétricas y ginecológicas de Norteamérica · doi:10.1016/s1885-9070(09)36008-4
Metabolic Complications of Polycystic Ovary Syndrome
Setji, T. L., & Brown, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_23
Use of oral contraceptives in the treatment of women with polycystic ovary syndrome
Stovall, D. W., Menke, M., Springel, E. H., Jarvis, A., & Karjane, N. W. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2.3.347
The feasibility of long-term treatment of polycystic ovary syndrome with GnRH-agonists
Berga, S. L. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350789
Self-citationHiperandrogenismo en la adolescente
Richard, C., Jonard, S., & Dewailly, D. (2006) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(06)46492-4
Renke, M. (2009)
Sarathkumar, T., & Jayashree, K. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i50b33446
A clinical study of puberty menorrhagia in the modern era at a tertiary health-care center
Kulkarni, N. N., Jagtap, A., & Athawale, P. (2023) · Muller Journal of Medical Sciences and Research · doi:10.4103/mjmsr.mjmsr_43_23
Recommended Therapies for Metabolic Defects in Polycystic Ovary Syndrome
Norman, R. J., Ruifrok, A. E., Moran, L., & Robker, R. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_16
Loucks, T. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Rajpoot, Z., Naveed, M., Mahmood, S., Azeem, A., Rehman, S. U., Khan, A. A., Al-Hoshani, N., Fakiha, K. G., Sagini, H. A., Mansouri, O. A., et al. (2026) · Open Chemistry · doi:10.1515/chem-2025-0238
Metadata
- Authors
- Korytkowski, M. T., Mokan, M., Horwitz, M. J., & Berga, S. L.
- Affiliations
- University of Pittsburgh (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-11
- Volume
- 80
- Issue
- 11
- Pages
- 3327-3334
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2113514432
- Cited by
- 140
- References
- 43
- Citations by year
- 2026: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 4
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (M01RR000056, 5 M01 RR00056, 2S07-RR-0541629)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, oral contraceptives, insulin resistance, insulin sensitivity index, hyperandrogenism, triglycerides, dyslipidemia, norethisterone, glucose disposal, hyperglycemic clamp, hyperinsulinemia
- MeSH terms
- Adult, Contraceptives, Oral, Female, Glucose Tolerance Test, Humans, Lipids, Polycystic Ovary Syndrome, Reference Values, Gonadal Steroid Hormones, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
